Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lowe Furge

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|May 19, 2011
Experimental approaches to microarray analysis of tumor samplesLaura Lowe Furge, Michael B Winter, Jacob I Meyers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2020
Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6Kevin D McCarty, Samuel A Ratliff, Kyle A Furge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2014
Mechanism-based inactivation of human cytochrome P450 3A4 by two piperazine-containing compoundsAmanda K Bolles, Rina Fujiwara, Erran D Briggs, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 10, 2013
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6Mara R Livezey, Erran D Briggs, Amanda K Bolles, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 7, 2019
Rolapitant Is a Reversible Inhibitor of CYP2D6Sarah M Glass, Sabrina M Leddy, Michael C Orwin, et al.
Archives of Biochemistry and Biophysics|March 30, 2004
Oltipraz inhibits inducible nitric oxide synthase in vitro and inhibits nitric oxide production in activated microglial cellsLaura Lowe Furge, Patrice R Fields, Whitney E Goode, et al.
Toxicology Letters|September 30, 2004
Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cellsRyan R Konwinski, Ramsi Haddad, Jamie A Chun, et al.
Drug Metabolism Letters|March 1, 2012
Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivatorsMara Livezey, Leslie D Nagy, Laura E Diffenderfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 23, 2011
Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adductionLeslie D Nagy, Catherine S Mocny, Laura E Diffenderfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2018
CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712Sarah M Glass, Cydney M Martell, Alexandria K Oswalt, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology|May 19, 2011
Experimental approaches to microarray analysis of tumor samplesLaura Lowe Furge, Michael B Winter, Jacob I Meyers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2020
Tryptophan-75 Is a Low-Energy Channel-Gating Residue that Facilitates Substrate Egress/Access in Cytochrome P450 2D6Kevin D McCarty, Samuel A Ratliff, Kyle A Furge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2014
Mechanism-based inactivation of human cytochrome P450 3A4 by two piperazine-containing compoundsAmanda K Bolles, Rina Fujiwara, Erran D Briggs, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 10, 2013
Metoclopramide is metabolized by CYP2D6 and is a reversible inhibitor, but not inactivator, of CYP2D6Mara R Livezey, Erran D Briggs, Amanda K Bolles, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 7, 2019
Rolapitant Is a Reversible Inhibitor of CYP2D6Sarah M Glass, Sabrina M Leddy, Michael C Orwin, et al.
Archives of Biochemistry and Biophysics|March 30, 2004
Oltipraz inhibits inducible nitric oxide synthase in vitro and inhibits nitric oxide production in activated microglial cellsLaura Lowe Furge, Patrice R Fields, Whitney E Goode, et al.
Toxicology Letters|September 30, 2004
Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cellsRyan R Konwinski, Ramsi Haddad, Jamie A Chun, et al.
Drug Metabolism Letters|March 1, 2012
Molecular analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivatorsMara Livezey, Leslie D Nagy, Laura E Diffenderfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 23, 2011
Substituted imidazole of 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Inactivates cytochrome P450 2D6 by protein adductionLeslie D Nagy, Catherine S Mocny, Laura E Diffenderfer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2018
CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712Sarah M Glass, Cydney M Martell, Alexandria K Oswalt, et al.
Pageof 2